Shares in biotech firm Moderna (NASDAQ:MRNA) rose more than 4% Monday after HSBC raised its rating on the stock from Hold to ...
The S&P 500 added 0.4% on Monday, Nov. 18, kicking off a trading week that will feature a highly anticipated earnings report ...
In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other high growth large cap stocks. BlackRock highlighted that its portfolio managers are broadly ...
In addition to Berenberg Bank, Moderna also received a Hold from HSBC’s Yifeng Liu in a report issued yesterday. However, on the same day, Piper Sandler maintained a Buy rating on Moderna ...
On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $39.77 which represents a decrease of $-2.37 or -5.62% from the prior close of $42.14. The stock opened at $42.05 and touched a ...
That includes Big Tech, which is currently making a series of peculiar investments in a few strange companies. This has nothing to do with tech. At least on the surface … Yet, these strange ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback